[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-338540-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-338540-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","dual-inhibition-of-oxidative-phosphorylation-and-glycolysis-exerts-a-synergistic-antitumor-effect-on-colorectal-and-gastric-cancer","Dual inhibition of oxidative phosphorylation and glycolysis exerts a synergistic antitumor effect on colorectal and gastric cancer","","Pyruvate is a metabolic hub linking oxidative phosphorylation (OXPHOS) and glycolysis, two major routes for cellular energy production. Prior cancer strategies targeting either pathway can trigger compensatory metabolic switching, limiting antitumor efficacy. This study tests whether colorectal and gastric cancer cells undergo such metabolic switching and whether dual suppression overcomes it. Using OXPHOS and glycolysis inhibitors, the work shows mutual pathway augmentation when targeted alone, while combined inhibition blocks the switch to glycolysis, causes energy depletion, and worsens the tumor microenvironment, synergistically strengthening antitumor effects. Hyperpolarized 13C-MRSI visualizes inhibitor-driven pyruvate flux and pathway remodeling in mouse models.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/dual-inhibition-of-oxidative-phosphorylation-and-glycolysis-exerts-a-synergistic-antitumor-effect-on-colorectal-and-gastric-cancer/338540/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/dual-inhibition-of-oxidative-phosphorylation-and-glycolysis-exerts-a-synergistic-antitumor-effect-on-colorectal-and-gastric-cancer/338540.png","ImageObject",300,407,{"name":42,"@type":43},"Clementine","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is dual inhibition of OXPHOS and glycolysis considered necessary in this study?","Question",{"text":63,"@type":64},"Cancer therapies that inhibit only one energy pathway can lead to compensation by the other pathway, producing insufficient antitumor effects. Dual, comprehensive suppression is therefore required to prevent metabolic switching.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What happens to glycolysis when OXPHOS is inhibited alone?",{"text":68,"@type":64},"OXPHOS inhibition enhances glycolysis and produces antitumor effects in colorectal and gastric cancer models in vitro and in vivo.",{"name":70,"@type":61,"acceptedAnswer":71},"How does combined inhibition change tumor metabolism compared with single inhibition?",{"text":72,"@type":64},"Adding glycolysis inhibition to OXPHOS inhibition blocks the metabolic switch from OXPHOS to glycolysis, leading to energy depletion and deterioration of the tumor microenvironment, which synergistically strengthens the antitumor effect.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},338540,1790179626,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","PLOS ONE  \nOPEN ACCESS  \nCitation: Aisu Y, Oshima N, Hyodo F, Elhelaly AE, Masuo A, Okada T, et al. (2024) Dual inhibition of oxidative phosphorylation and glycolysis exerts a synergistic antitumor effect on colorectal and gastric cancer by creating energy depletion and preventing metabolic switch. PLoS ONE 19(12):  \ne0309700 . [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0309700  \nEditor: Ming Tan, China Medical University (Taiwan), TAIWAN  \nReceived: April 3, 2024  \nAccepted: August 18, 2024  \nPublished: December 12, 2024  \nCopyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.  \nData Availability Statement: All relevant data are within the manuscript and its Supporting information files.  \nFunding: The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation. This study received funding from the following sources: Grant Number:  \nJP22J13060 from Japan Society for the Promotion of Science(JSPS) KAKENHI for YA [https://www](https://www).  \nRESEARCH ARTICLE  \nDual inhibition of oxidative phosphorylation and glycolysis exerts a synergistic antitumor effect on colorectal and gastric cancer by creating energy depletion and preventing metabolic switch  \nYuki Aisu1, Nobu Oshima1,2 *, Fuminori Hyodo3,4, Abdelazim Elsayed Elhelaly4, Akihiko Masuo1, Tomoaki Okada1, Shigeo Hisamori1, Shigeru Tsunoda1, Koya Hida1, Tomonori Morimoto1, Hiroyuki Miyoshi5, Makoto M. Taketo5, Masayuki Matsuo3, Leonard M. Neckers6, Yoshiharu Sakai7, Kazutaka Obama1  \n1 Department of Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan, 2 Department of Surgery, Kobe City Medical Center General Hospital, Kobe, Japan, 3 Department of Radiology, Gifu University Hospital, Gifu, Japan, 4 Department of Radiology, Frontier Science for Imaging, Gifu University, Gifu, Japan, 5 Colon Cancer Project, Kyoto University Hospital-iACT, Kyoto University Graduate School of Medicine, Kyoto, Japan, 6 National Cancer Institute, Urologic Oncology Branch, Center for Cancer Research, NIH, Bethesda, Maryland, United States of America, 7 Department of Gastrointestinal Surgery, Osaka Red Cross Hospital, Osaka, Japan  \n* [noshima@kuhp.kyoto-u.ac.jp](noshima@kuhp.kyoto-u.ac.jp)  \nAbstract  \nPyruvate is situated at the intersection of oxidative phosphorylation (OXPHOS) and glycolysis, which are the primary energy-producing pathways in cells. Cancer therapies targeting these pathways have been previously documented, indicating that inhibiting one pathway may lead to functional compensation by the other, resulting in an insufficient antitumor effect. Thus, effective cancer treatment necessitates concurrent and comprehensive suppression of both. However, whether a metabolic switch between the metabolic pathways occurs in colorectal and gastric cancer cells and whether blocking it by inhibiting both pathways has an antitumor effect remain to be determined. In the present study, we used two small molecules, namely OXPHOS and glycolysis inhibitors, to target pyruvate metabolic pathways as a cancer treatment in these cancer cells. OXPHOS and glycolysis inhibition each augmented the other metabolic pathway in vitro and in vivo. OXPHOS inhibition alone enhanced glycolysis and showed antitumor effects on colorectal and gastric cancer cells in vitro and in vivo. Moreover, glycolysis inhibition in addition to OXPHOS inhibition blocked the metabolic switch from OXPHOS to glycolysis, causing an energy depletion and deterioration of the tumor microenvironment that synergistically enhanced the antitumor effect of OXPHOS inhibitors. In addition, using hyperpolarized 13C-magnetic resonance spectroscopic imaging (HP-MRSI), which enables real-time and in vivo monitoring of molecules contai","cbCaijlWFPMpDb8b","https://ap.wps.com/l/cbCaijlWFPMpDb8b","pdf",1990768,21,"English","# Abstract\n## Dual inhibition strategy\n## Energy depletion and metabolic switch\n## In vivo monitoring with hyperpolarized 13C-MRSI","[{\"question\":\"Why is dual inhibition of OXPHOS and glycolysis considered necessary in this study?\",\"answer\":\"Cancer therapies that inhibit only one energy pathway can lead to compensation by the other pathway, producing insufficient antitumor effects. Dual, comprehensive suppression is therefore required to prevent metabolic switching.\"},{\"question\":\"What happens to glycolysis when OXPHOS is inhibited alone?\",\"answer\":\"OXPHOS inhibition enhances glycolysis and produces antitumor effects in colorectal and gastric cancer models in vitro and in vivo.\"},{\"question\":\"How does combined inhibition change tumor metabolism compared with single inhibition?\",\"answer\":\"Adding glycolysis inhibition to OXPHOS inhibition blocks the metabolic switch from OXPHOS to glycolysis, leading to energy depletion and deterioration of the tumor microenvironment, which synergistically strengthens the antitumor effect.\"}]","Dual inhibition of oxidative phosphorylation and glycolysis exerts a synergistic antitumor effect on colorectal and gastric cancer | PDF",1790024116,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b364b6f38308267fd5d61799bf3bb6cd.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ec6f1a9a66afe7107dbc963043d2b0c.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a61833f641088dde93596682f96d993b.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d0368837639bb717a2d64000c73e98dc.webp",980,1268]